{Reference Type}: Editorial
{Title}: The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most?
{Author}: Migliaccio I;Biganzoli L;Malorni L;
{Journal}: Ann Oncol
{Volume}: 35
{Issue}: 8
{Year}: 2024 Aug
{Factor}: 51.769
{DOI}: 10.1016/j.annonc.2024.05.542